CONCORDBIO logo

Concord Biotech Limited

CONCORDBIO·NSE·
1,446.30 -38.00 (-2.56%)
Market Cap15169.35 Cr
PE Ratio57.46
Volume72,926
Day High - Low1492.80 - 1440.90
52W High-Low1730.00 - 987.00
DocStoX Score
5.2/10
Weak
Fair Value
Sign in to see
ROE
13.03%
Average
P/E
57.46x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day1441
1493
52W987.00
1730
DocStoX take

Supported by risk (9.1) and quality (7.4), but held back by valuation (0.0). Risk looks strong at 9.1, but that is offset by valuation at 0.0 and growth at 2.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.2
/10
Weak
Quality
Solid
ROE 13.0%
Valuation
Expensive
P/E 57.5×
Growth
Flat
Revenue +11.3% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Firm
62% of 52-week range

At a glance

Market Cap
₹15,169 Cr
52W High / Low
₹1730 / ₹987
Dividend Yield
0.51%
Promoter Holding
44.08%
EPS (TTM)
₹25.17
Book Value
₹193.23

Key highlights

  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Healthy net margin (25%)
  • Valuation is weak (0.0/10)
3 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

CONCORD BIOTECH LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.